In a statement, Bristol-Myers Squibb Co and Eisai Co said, they had entered into an agreement to jointly develop and market an experimental cancer drug worth up to $3.10 billion. Bristol-Myers would pay $650 million, including for research and development… Read More ›
Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
The Japanese healthcare firm wants to acquire Bristol-Myers Squibb’s over-the-counter drugs business. On Wednesday, France-headquartered Bristol-Myers Squibb Co has received an offer from Taisho Pharmaceutical Holdings Co Ltd, a Japanese healthcare firm, to acquire its over-the-counter drugs business UPSA for… Read More ›
The game changing method founded by researchers Tasuku Honjo and James Allison was used to create the drug Opdivo which was co-developed by Ono Pharmaceutical Co and Bristol-Myers Squibb Co. On Tuesday, shares of Japanese drugmaker Ono Pharmaceutical Co touched… Read More ›
manageria.biz 